- Once-daily opicapone 50 mg with carbidopa/levodopa helped achieve and maintain plasma concentrations of levodopa in patients with PD.- Maximum COMT inhibition was nearly 85% at day 14.
- Adding once-daily opicapone 50 mg to carbidopa/levodopa therapy helped achieve and maintain plasma concentrations of levodopa in patients with Parkinson’s disease, according to research in Clinical Neuropharmacology.
“The findings presented in this study address a major unmet need in the treatment of PD and more consistent delivery of [levodopa] to the brain, which continues to be a challenge for optimizing treatment of PD,” Eiry W. Roberts, MD, chief medical officer at Neurocrine Biosciences, told